Third Harmonic Bio, Inc.
THRD
$5.16
$0.030.59%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -91.73% | -87.92% | -41.63% | 13.53% | 40.50% |
| Total Depreciation and Amortization | 0.00% | 0.00% | 71.43% | 300.00% | 1,200.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 75.40% | 32.11% | -7.29% | -12.87% | -11.20% |
| Change in Net Operating Assets | -113.22% | 242.69% | -253.15% | -145.93% | -2,321.88% |
| Cash from Operations | -100.29% | -95.39% | -122.40% | 5.72% | 39.63% |
| Capital Expenditure | -900.00% | -- | -- | -- | 97.22% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -900.00% | -- | -- | -- | 97.22% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -82.54% | 1,631,066.67% | 2,162.07% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | 53.71% |
| Cash from Financing | -73.68% | 85,950.88% | 2,162.07% | -- | 191.20% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -129.31% | 1,061.37% | -84.15% | 6.46% | 52.83% |